Patent Yard Sign in
Canadian application, no grantCanada

Liver function controlling agents

CA 2374273 A1 · Owner: Takeda Chemical Industries, Ltd. · Inventors: Hikichi, Yukiko; Matsui, Hideki; Shintani, Yasushi

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Novel liver function controlling agents which contain proteins containing amino acid sequences which are the same or substantially the same as the amino acid sequences represented by SEQ ID NO:1 SEQ ID NO:2, SEQ ID NO:3 or SEQ ID , NO:31. These liver function controlling agents are useful as preventives/remedies for diseases such as liver insufficiency hepatitis, liver cancer or liver cirrhosis.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed May 19, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 19, 2020.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 19, 2022.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMay 19, 2000
GrantedNo grant recorded
Term endedMay 19, 2020
Patent numberCA 2374273 A1
Classification (IPC)A61K38/17 +2 more

Timeline

Timeline From CIPO dates

2001200320052007200920112013201520172019Application filedMay 19, 2000Term endedMay 19, 2020

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.